Results 61 to 70 of about 8,099 (196)

Use of the IlluminOss Photodynamic Bone Stabilisation System Following Stereotactic Body Radiation Therapy for Limb‐Sparing in Six Dogs With Presumptive Appendicular Osteosarcoma

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Osteosarcoma is the most common primary bone tumour in dogs, with approximately 75% of cases occurring in the appendicular skeleton. Standard‐of‐care therapy consists of limb amputation followed by carboplatin chemotherapy. A minority of dogs have limb‐sparing treatments including stereotactic body radiation therapy (SBRT) or surgery. SBRT has
Emily A. Pope   +6 more
wiley   +1 more source

Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non–small-cell lung cancer: a propensity-matched retrospective study

open access: yesBMC Cancer, 2021
Background This retrospective study aimed to evaluate the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with stereotactic body radiation therapy (SBRT) and to elucidate potential mechanisms of acquired resistance ...
Xia Wang   +6 more
doaj   +1 more source

Latent density discrepancies in commercial lung‐equivalent inserts and their clinical dosimetric impact

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 7, July 2026.
Abstract Background Accurate heterogeneity correction in high‐precision radiotherapy relies on precise computed tomography (CT) number‐to‐density conversion via the Hounsfield unit look‐up table (HLUT). While physical properties of tissue‐equivalent materials are generally assumed consistent with manufacturer specifications, an independent audit ...
Minoru Nakao   +5 more
wiley   +1 more source

Systematic improvement of SBRT dose gradients.

open access: yes, 2012
154 Background: Stereotactic body radiation therapy (SBRT) offers excellent local control for early stage lung cancer. SBRT utilizes high fractional doses of radiation in 5 or fewer treatments. Normal tissue risk is substantial necessitating steep dose
Amanda Scott   +5 more
core   +1 more source

Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review

open access: yesCost Effectiveness and Resource Allocation, 2020
Stereotactic body radiotherapy (SBRT) is a novel noninvasive treatment for hepatocellular carcinoma. SBRT can achieve effective local control, but it requires a relatively high input of resources; this systematic review was performed to assess the cost ...
Haiyin Wang   +5 more
doaj   +1 more source

Feasibility Study of Combined Systemic Therapy and Carbon‐Ion Radiotherapy for Hepatocellular Carcinoma Patients

open access: yesCancer Medicine, Volume 15, Issue 7, July 2026.
ABSTRACT Background Recent advances in systemic therapy, including tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs), have improved outcomes for hepatocellular carcinoma (HCC) and enabled downstaging strategies that allow subsequent local treatments. Carbon‐ion radiotherapy (CIRT) can provide excellent tumor control with minimal
Daijiro Kobayashi   +6 more
wiley   +1 more source

Clinical Utility of 68Ga‐DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction 68Ga‐DOTATOC positron emission tomography/computed tomography (PET/CT) targets somatostatin receptors (SSTRs) and is an established molecular imaging modality for neuroendocrine tumors (NETs). Although SSTR expression has been reported in renal cell carcinoma (RCC), its clinical utility remains unclear. Case Presentation A 76‐year‐
Yuta Mine   +9 more
wiley   +1 more source

Executive summary of American Radium Society Appropriate Use Criteria for the treatment of locoregionally recurrent rectal cancer

open access: yesCancer, Volume 132, Issue 12, 15 June 2026.
Abstract This literature‐based systematic review and associated guidelines provide evidence‐based paradigms for the management of locoregionally recurrent rectal cancer (LRRC). This multispecialty committee included gastrointestinal radiation and medical oncology, gastroenterology, radiology, and colorectal surgery.
Eric D. Miller   +18 more
wiley   +1 more source

IMRT, IGRT, SBRT - Advances in the Treatment Planning and Delivery of Radiotherapy

open access: yes, 2011
Over the last 4 years, IMRT, IGRT, SBRT: Advances in the Treatment Planning and Delivery of Radiotherapy has become a standard reference in the field.
Meyer, J. L., Meyer, J.L.
core  

Home - About - Disclaimer - Privacy